Compare SRPT & SHOO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SRPT | SHOO |
|---|---|---|
| Founded | 1980 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Shoe Manufacturing |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.4B | 2.7B |
| IPO Year | 2000 | 1996 |
| Metric | SRPT | SHOO |
|---|---|---|
| Price | $18.83 | $39.71 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 28 | 8 |
| Target Price | $25.76 | ★ $42.75 |
| AVG Volume (30 Days) | ★ 2.3M | 1.8M |
| Earning Date | 04-17-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 2.11% |
| EPS Growth | ★ 140.34 | 2.17 |
| EPS | N/A | ★ 0.30 |
| Revenue | $1,901,979,000.00 | ★ $2,282,927,000.00 |
| Revenue This Year | $14.67 | $13.14 |
| Revenue Next Year | N/A | $10.88 |
| P/E Ratio | ★ N/A | $132.97 |
| Revenue Growth | ★ 52.97 | 15.21 |
| 52 Week Low | $10.42 | $19.05 |
| 52 Week High | $109.55 | $46.88 |
| Indicator | SRPT | SHOO |
|---|---|---|
| Relative Strength Index (RSI) | 43.14 | 42.71 |
| Support Level | $17.45 | $38.49 |
| Resistance Level | $18.70 | $40.30 |
| Average True Range (ATR) | 1.00 | 2.15 |
| MACD | -0.01 | 0.03 |
| Stochastic Oscillator | 37.11 | 39.57 |
Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.
Steven Madden Ltd designs and sells brand-name and private-label footwear and accessories. Its products are geared toward fashion-conscious adults and children. The company sells its products through department stores and other retailers as well as its stores and websites. The company's revenue comes from its operating segments: Wholesale Footwear, Wholesale Accessories or Apparel, Direct-to-Consumer, and Licensing. The wholesale footwear segment accounts for the majority of revenue.